FDA Inspection 994493 — Ingenus Pharmaceuticals NJ, LLC.
The FDA completed an inspection of Ingenus Pharmaceuticals NJ, LLC. on November 16, 2016 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fairfield, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)